Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034
... RR-FL; however, follow-up remains limited. Identifying appropriate patients for CAR T-cell therapy stands out as a paramount challenge, given its expensive nature and aggressive treatment approach. The FDA has approved four CAR-Ts in different subtypes ... Read More
-
Gastroparesis - Market Insight, Epidemiology And Market Forecast - 2034
... also known as esophagus cancer, develops in the cells that line the esophagus and occurs when a malignant tumor arises in the esophagus lining. Esophageal malignancies are often discovered as a result of a person’s ... Read More
-
Giant-Cell Arteritis - Market Insight, Epidemiology And Market Forecast - 2034
... originates from melanocytes, pigment-producing cells, and can potentially metastasize, commonly to the liver. Ocular melanoma can be divided into uveal and non-uveal melanoma. Uveal melanoma (~95%) comprises the larger group of ocular melanoma and consists ... Read More
-
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034
... crucial retinal components such as retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris in the macula. Although this condition is not uncommon in clinical practice, it can go undetected until the atrophy involves the fovea and ... Read More
-
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034
... million, which is further expected to increase by 2034. In September 2023, concizumab was approved in Japan under the brand name ALHEMO for treating hemophilia A and B with inhibitors. Novo Nordisk expects to launch ... Read More
-
Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034
... the urine (nephrotic syndrome) and is primarily an autoimmune condition. There is currently no specific approved drugs for IMN, and management typically focuses on supportive care. The market is anticipated to witness a substantial positive ... Read More
-
Schizophrenia- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Schizophrenia: Understanding Schizophrenia: Overview ... Read More
-
Retinitis Pigmentosa- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Retinitis ... Read More
-
Acute Kidney Injury- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Anterior Uveitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Small Molecule API Global Market Report 2024
... Albemarle Corporation; Boehringer Ingelheim International GmbH Small Molecule API Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This ... Read More
-
Epidermolysis Bullosa Market Insight, Epidemiology And Market Forecast - 2034
... cases. In the absence of intervention, approximately 90% of males experience kidney failure by the age of 40, whereas females less commonly and more gradually progress to kidney failure. The majority of Alport syndrome patients ... Read More
-
Alport Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... Currently, newly diagnosed PTCL patients are usually treated with anthracycline-based chemotherapy regimens. For most subtypes of PTCL, the initial treatment is typically a combination chemotherapy regimen, such as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), CHOEP ... Read More
-
Epidermolysis Bullosa - Epidemiology Forecast - 2034
... cases were attributed to Epidermolysis Bullosa Simplex. Dystrophic Epidermolysis Bullosa accounted for 30% of prevalent cases, while Junctional Epidermolysis Bullosa constituted just 5% of the observed cases. In 2023, Japan accounted for approximately 4% of ... Read More
-
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2024-2032
... Group expects the market to reach US$ 19.3 Billion by 2032, exhibiting a growth rate (CAGR) of 10.4% during 2024-2032. The growing focus on personalized medicine among the masses, the increasing investments in research and ... Read More
-
Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2024-2032
... Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2024-2032 The global hormone replacement therapy market size reached US$ 9.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.1 Billion by ... Read More
-
Albumin Market Report by Product (Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin), Application (Therapeutics, Drug Formulation and Vaccine, Component of Media, and Others), End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Research Institutes), and Region 2024-2032
... and Region 2024-2032 The global albumin market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% ... Read More
-
Restless Legs Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... outbreak of COVID-19 has many effects, such as travel bans, flight cancellations, supply chain disruption, stock market unpredictability, falling business assurance, growing panic among the population, and uncertainty about the future had a great impact ... Read More
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2024-2032
... and Region 2024-2032 The global cephalosporin market size reached US$ 19.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.4 Billion by 2032, exhibiting a growth rate (CAGR) of 2.6% ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
-
Chagas Disease: American trypanosomiasis Market
... a detailed competitive environment analysis. The scope of this report covers treatment throughout Latin America. Report Includes: An overview of the global chagas disease (T. cruzi infection) market Analyses of the global market trends, with ... Read More
-
Hepatitis B Virus (HBV) Global Market Report 2024
... Healthcare PayersCovering: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmon La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc. Hepatitis B Virus (HBV) Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Generative AI in Pharmaceutical Market Report: Trends, Forecast and Competitive Analysis to 2030
... the clinical trial research, drug discovery, research and development markets. Generative AI in the global pharmaceutical market is expected to grow with a CAGR of 29.5% from 2024 to 2030. The major drivers for this ... Read More
-
Biosimulation Market Report: Trends, Forecast and Competitive Analysis to 2030
... academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding ... Read More
-
Biomarkers Market Size, Share & Trends Analysis Report By Type (Efficacy, Validation), By Product, By Application (Drug Discovery & Development, Personalized Medicine), By Disease, By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global biomarkers market size is expected to reach USD 194.21 billion by 2030, registering a CAGR of 13.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. ... Read More
Research Assistance
